Skip to content

Low Risk Stock Market Trading & Investing

Menu

Primary menu

  • HOME
  • Learn To Trade
  • Contact

Data on Pfizer’s Lyrica – Analyst Blog

Posted on 00:35 11/20 by Trade Advantage

Pfizer Inc. ( PFE ) recently presented disappointing top-line data from a phase III study that was conducted to evaluate a once-daily dose of Lyrica (pregabalin) in epilepsy patients.

Go here to read the rest:
Data on Pfizer’s Lyrica – Analyst Blog

This entry was posted in Futures by Trade Advantage. Bookmark the permalink.

Post navigation

← Previous Previous post: Forex: AUD/USD comfortable around 1.04; RBA eyed
Next → Next post: Forex Flash: RBA disappointment is AUD positive – NAB

Primary Sidebar Widget Area

LEARN TO TRADE
SUBSCRIBER LOGIN

Monthly Newsletter

FIND OUT MORE

Low Risk, Long Term Investing

  • Cookies, Privacy & Disclaimer
  • Learn To Trade
  • Why Retail Traders Fail?
  • The Dow Divisor – What is it? -How Is it used in Investor Psychology
  • A Method In Their Madness
  • CVX Gaps and Volume Trading
  • APPL Gaps
  • DIS – Disney
  • XOM charts and notes
  • JPM – JP Morgan Chase
  • WMT Gaps
  • MSFT – Microsoft Surge
  • BA – Boeing Charts

Cookies, Private Policy & Disclaimer

Click Here to read a full explanation on our policies for Cookies

 U.S. Government Required Disclaimer – Commodity Futures Trading Commission. *Futures, options, and spot currency trading have large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don’t trade with money you can’t afford to lose. This website is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this website. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 – HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

Privacy Policy

We respect your privacy and will never share your email address with any outside party. We will send you webinar and/or other opportunities we feel you may be interest in, but in the event that you wish to opt out, please let us know. If you receive any unwanted mails from our companies, then please also let us know, we will remove you from our database immediately. Any SPAM or unwanted mail generators who have utilised our company information will be prosecuted to the full – It is not acceptable practice. We may use third-party advertising companies to provide ads when you visit our website. These companies may use information (not including your name, address, email address, or telephone number) about your visits to this and other websites in order to provide advertisements about goods and services of interest to you. We may use affiliates in the course of running our web-sites, we may get paid an affiliate commission if you purchase goods from them, via these adverts.

TRADE ADVANTAGE - Futures, Stocks & Forex Data, News & Reviews - Live ES Trade Room

All contents of the Service are provided for information and educational purposes only. You agree that the Service should not be interpreted as investment advice, as an endorsement of any security, or as an offer to buy or sell any financial instrument. Trade-Advantage is not a registered broker dealer, or financial advisor. Trade-Advantage does not provide personal investment advice. You also understand and agree that, from time to time, any or all of the information providers or their affiliates may hold positions in financial instruments mentioned and that they may trade for their own account based on this information. Members and visitors to Trade-Advantage should assume at all times that any and every stock, ETF, or other investments that is discussed, listed, and or referred to or which appear at the website in any form may also be currently owned by Trade-Advantage owners, employees or affiliates.
  • Facebook
  • Twitter
  • YouTube
Copyright © 2025 . All Rights Reserved.
Theme: Catch Box by Catch Themes
Scroll Up
This website uses cookies to improve your experience. By continuing to use our site you agree to their useAccept Read More
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT